U.S. markets close in 5 hours 25 minutes

Zoetis Inc. (ZTS)

NYSE - Nasdaq Precio en tiempo real. Moneda en USD.
Añadir a la lista de seguimiento
182.49+0.88 (+0.48%)
A partir del 10:35AM EDT. Mercado abierto.

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Sector(es)Healthcare
IndustriaDrug Manufacturers - Specialty & Generic
Empleados a tiempo completo14,100

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Ms. Kristin C. PeckCEO & Director3.54M5.2M1971
Mr. Wetteny N. JosephExecutive VP & CFO1.6MN/D1972
Ms. Wafaa MamilliEVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health1.36MN/D1967
Ms. Heidi C. ChenEmployee Advisor1.24MN/D1967
Dr. Robert J. Polzer Ph.D.Executive VP and President of Research & Development1.18M54.13k1969
Mr. Steven FrankVice President of Investor RelationsN/DN/DN/D
Ms. Roxanne LaganoExecutive VP, General Counsel & Corporate SecretaryN/DN/D1965
Mr. William PriceVP & Chief Communications OfficerN/DN/DN/D
Ms. Jeannette Ferran AstorgaExecutive VP of Corporate Affairs & Communications and Chief Sustainability OfficerN/DN/D1975
Mr. Nick AshtonExecutive VP and President of Global Manufacturing & SupplyN/DN/D1973
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Gestión corporativa

La calificación ISS Governance QuickScore de Zoetis Inc. a partir del 1 de julio de 2024 es 3. Las puntuaciones principales son Auditoría: 6; Junta: 1; Derechos del accionista: 6; Compensación: 2.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.